Affiliate-supportedIndependent editorialWe never sell medicationSee how
FDA Compliance Notice
Henry Meds offers compounded GLP-1 medications. As of March 2026, the FDA has issued warning letters to multiple telehealth providers regarding compounded GLP-1 marketing. Discuss FDA-approved alternatives with your provider.
Learn more →From
$199/mo
Score
6.0/10
From
$79/mo
Score
7.0/10
Henry Meds and Mochi Health are both GLP-1-class medications. Choice between them depends on FDA-approved indication (weight management vs type 2 diabetes), cost without insurance, dosing schedule, side-effect profile, and your prescriber's clinical judgment. See the full side-by-side comparison and decision-tree below to identify which fits your situation. Always confirm choice with your prescriber — we don't sell or prescribe, we compare.
Henry Meds wins 1 · Mochi Health wins 1
Henry Meds
1 of 4 wins
Mochi Health
1 of 4 wins